American International Group’s Neon Therapeutics, Inc. Common Stock NTGN Stock Holding History

American International Group’s Portfolio NTGN Stock Details NTGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-8,489	Closed	-$22K	–	3250
2020 Q1	$22K	Sell	8,489 -365	-4%	-$598	﹤0.01%	2921
2019 Q4	$10K	Sell	8,854 -75	-0.8%	-$120	﹤0.01%	3066
2019 Q3	$15K	Sell	8,929 -62	-0.7%	-$189	﹤0.01%	3049
2019 Q2	$43K	Sell	8,991 -332	-4%	-$1.86K	﹤0.01%	2980
2019 Q1	$60K	Buy	9,323 +5,169	+124%	+$27.1K	﹤0.01%	2822
2018 Q4	$21K	Sell	4,154 -31	-0.7%	-$217	﹤0.01%	3020
2018 Q3	$36K	Buy	+4,185	New	+$46.4K	﹤0.01%	3101

American International Group's NTGN Position: Q2 2020 in Review

American International Group sold out of Neon Therapeutics, Inc. Common Stock (NTGN) in Q2 2020, closing a stake of 8,489 shares — an estimated $22K sold.

American International Group first reported a position in NTGN in Q3 2018 and held it in 7 quarters. The position peaked at $60K in Q1 2019. 0 funds tracked by Wall St. Rank hold NTGN as of Q2 2020.

American International Group reported no remaining Neon Therapeutics, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
American International Group sold 8,489 Neon Therapeutics, Inc. Common Stock shares in Q2 2020, an estimated $22K.
American International Group first reported a position in Neon Therapeutics, Inc. Common Stock in Q3 2018 and held it in 7 quarters.
American International Group's Neon Therapeutics, Inc. Common Stock position peaked at $60K in Q1 2019.
0 funds tracked by Wall St. Rank held Neon Therapeutics, Inc. Common Stock as of Q2 2020.

Based on American International Group's 13F filing for Q2 2020, filed 12 Aug 2020.